How to reduce your skin cancer risk
A doctor-led guide to reducing skin cancer risk, for everyone and especially after a first skin cancer. The foundation is sun protection when the UV Index is 3 or above — clothing, hats, shade and sunscreen — plus no tanning beds and regular skin checks. Evidence-based extras layer on top: vitamin B3, field therapy, the off-label HPV vaccine, and vitamin D from diet not the sun.

By Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA
Last reviewed 2026-06-06 · 10 min read · Editorial policy
Quick summary
Most skin cancer is driven by UV exposure, which you can change. The foundation for everyone is sun protection when the UV Index is 3 or above — clothing, hats, shade and daily sunscreen — plus no tanning beds and regular skin checks. If you have already had a skin cancer, your risk of another is higher, so we add targeted, evidence-based steps: vitamin B3 (nicotinamide), field therapy for the surrounding sun-damaged skin, the off-label HPV vaccine for a heavy actinic-keratosis burden, and getting vitamin D from diet or a vitamin supplement rather than the sun. None of these replace sun protection — they layer on top of it.
Skin cancer is one of the most preventable cancers, because its biggest driver — ultraviolet radiation — is something we can act on. This guide covers the foundations that apply to everyone, and then the additional, evidence-based steps we use for people at higher risk, including those who have already had a skin cancer.
If you have had a skin cancer before, the goal shifts from detection alone to active secondary prevention — repairing the underlying sun damage and lowering the chance of the next lesion forming. Having had one non-melanoma skin cancer substantially raises the risk of another, and that risk is highest in the first few years. (9)
1. Sun protection — the foundation
The single most important strategy, for everyone, is reducing new UV exposure. Past damage cannot be undone, but preventing further damage prevents new cancers. The practical rules are built around the UV Index: whenever it reaches 3 or above, use a combination of measures rather than relying on any one. (2)
- Mind the midday gap. UV is strongest roughly 10am–4pm in the warmer months — minimising exposure then is the most effective way to cut your cumulative UV load.
- Cover up. Loose UPF 50+ clothing, a broad-brim hat and sunglasses are physical barriers that do not wash off or get forgotten — far more reliable than sunscreen alone for the back, arms and torso. See sun protection beyond sunscreen →.
- Seek shade. Good shade markedly reduces UV, though scattered and reflected UV still reach you.
- Use sunscreen on the rest. Apply broad-spectrum SPF 50/50+ to exposed skin and reapply every two hours outdoors. Regular sunscreen use is not just theory — in a randomised trial, regular sunscreen users developed fewer melanomas than the discretionary-use group. (1) See our sunscreen guide →.
- Never use tanning beds. Sunbed use increases melanoma risk — most of all when first use is before age 35 — and UV-emitting solariums are classed as carcinogenic to humans. (3)
For the high-risk patient especially, sun protection is a medical necessity: new UV on top of old damage is the spark that ignites new cancers.
2. Vitamin B3 (nicotinamide)
Nicotinamide gives skin cells an energy boost (via NAD⁺) that supports repair of UV-induced DNA damage and reduces UV-driven immune suppression — helping correct damage before it can become cancer.
- The evidence: in the randomised ONTRAC trial, 500 mg twice daily reduced new non-melanoma skin cancers by 23% in high-risk patients. (4) A large 2025 cohort study (nearly 34,000 patients) found the benefit was greatest — about a 54% reduction — when nicotinamide was started after the first skin cancer, and smaller when started later. (5)
- The method: 500 mg twice daily, long term. Use nicotinamide / niacinamide, not niacin (nicotinic acid), which causes flushing.
Vitamin B3 also helps applied to the skin — a niacinamide serum (around 10%) has photoprotective effects and can reduce actinic keratoses over time (6) — and it occurs naturally in food, though diet alone cannot reach the ~1,000 mg/day used for prevention. (7)
For the full protocol — dosing, brands (and how many tablets a day), the topical serum, dietary B3, statin and safety notes, and the transplant caveat — see the vitamin B3 (nicotinamide) guide →.
3. Field therapy — treating the “soil”
Removing a single skin cancer is like pulling one weed; field therapy treats the whole sun-damaged area (the “soil”) to clear invisible, sub-clinical damage. Using prescription creams or laser-assisted photodynamic therapy, we “reset” an at-risk area to lower the chance of the next cancer forming — see treating sun damage with field therapy → and actinic keratosis treatment →.
4. The HPV vaccine (Gardasil 9, off-label)
For patients with a high actinic-keratosis burden — frequently having pre-cancers frozen or treated — there is emerging interest in the HPV vaccine. The 2025 VAXAK randomised trial found the 9-valent HPV vaccine reduced actinic keratosis counts more than placebo in immunocompetent patients. (8) It is off-label, not standard care, and supplementary to the steps above — see Gardasil 9 for AK prevention →.
5. Precision surveillance
After a skin cancer, the “wait and see” approach is replaced by a structured surveillance plan, because the risk of a further skin cancer is real and concentrated in the first few years. (9) Regular professional checks catch new lesions and field changes early, when treatment is simplest — see life after a skin cancer diagnosis → and our skin check hub →.
6. Vitamin D — the nuanced picture
People rightly worry that strict sun protection could affect vitamin D. You do not need deliberate sun exposure to maintain it: get vitamin D from diet and a supplement (oily fish, eggs and fortified foods; a common maintenance dose is 1,000–2,000 IU/day, with your doctor advising if you are deficient). (2)
The relationship between vitamin D and skin cancer is genuinely nuanced. Low vitamin D at the time of a melanoma diagnosis is associated with thicker tumours and, in some studies, poorer survival. (12) And there is real biological plausibility that vitamin D could help: acting through the vitamin D receptor, it can slow cell proliferation, encourage normal cell maturation, dampen inflammation, quieten cancer-promoting growth signals (such as the Wnt/β-catenin pathway) and support repair of UV-damaged DNA — and mice lacking the vitamin D receptor develop more UV-induced skin tumours.
Despite that promise, the research on actually taking vitamin D has generally been disappointing. Randomised trials of vitamin D supplements have not reduced skin cancer, and a randomised melanoma trial found no improvement in relapse or survival despite successfully raising vitamin D levels. (13) The likeliest explanation for the favourable associations is confounding — sunlight raises both vitamin D and skin cancer risk, so a high vitamin D level often just marks more sun exposure or better general health.
The practical takeaway: correct a genuine deficiency for your overall health (your doctor may check your level around a melanoma diagnosis), but do not chase high vitamin D levels as a skin cancer strategy, and never use the sun as your vitamin D source. For the full evidence explained simply, see vitamin D and skin cancer — what the evidence shows → and nutrition and vitamin D for sun-avoidant patients →.
7. Special considerations for high-risk groups
Some patients need more intensive, individualised protocols:
- Organ transplant recipients — a markedly higher risk of aggressive squamous cell carcinoma. (10)
- Immunosuppressed patients — reduced immune surveillance of the skin.
- Outdoor workers — occupational UV is an established risk factor that roughly doubles squamous cell carcinoma risk. (11)
For these groups, physical protection and structured surveillance matter even more — see advanced protection for high-risk groups →.
Book a skin check
A professional skin check is the cornerstone of prevention — for early detection and for building the right ongoing plan for you.
Frequently asked questions
-
Is skin cancer preventable?
To a large extent, yes. Most non-melanoma skin cancer and a meaningful share of melanoma is driven by UV exposure, which is modifiable. Daily UV protection, changing behaviour when the UV Index is 3 or above, avoiding tanning beds, and regular skin checks all reduce both how often skin cancer occurs and how serious it is. -
Does taking vitamin B3 mean I can spend more time in the sun?
No. Nicotinamide is an added layer of protection — it is not sunscreen in a pill. It helps skin cells repair existing UV damage, but it cannot block new UV. You must keep up rigorous sun protection regardless. The evidence is also strongest for people who have already had a skin cancer. -
I had Gardasil as a teenager — do I need it again for skin cancer?
Probably not. The emerging skin cancer research focuses on older patients with a heavy actinic keratosis burden who were never vaccinated. If you have already been vaccinated, a booster is likely unnecessary, but it can be discussed at a clinical review. HPV vaccination for skin cancer is off-label and not yet standard care. -
Why are my skin checks so frequent after a diagnosis?
Because having had one skin cancer substantially raises the chance of another, and that risk is highest in the first few years. Frequent checks let us catch new lesions and field changes early — the difference between a simple cream or minor procedure and major surgery. -
Are tanning beds really that dangerous?
Yes. Solariums emit concentrated UV and are classified by the IARC as carcinogenic to humans. A meta-analysis found sunbed use increases melanoma risk, with the greatest danger when first use is before age 35. There is no safe level of tanning-bed use, which is why commercial solariums are banned in Australia. -
Should I avoid the sun completely to prevent vitamin D deficiency problems?
You do not need deliberate sun exposure for vitamin D. If you are at high risk of skin cancer, the safer approach is to get vitamin D from diet and a supplement while protecting your skin. A doctor can check your level and advise a dose if needed.
References
- Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up (Nambour). J Clin Oncol. 2011;29(3):257-263.
- Cancer Council Australia. Position statement — Sun protection and sun exposure (UV Index 3+, the SunSmart steps, and vitamin D).
- Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012;345:e4757.
- Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention (ONTRAC). N Engl J Med. 2015;373(17):1618-1626.
- Breglio KF, Knox KM, Hwang J, et al. Nicotinamide for skin cancer chemoprevention. JAMA Dermatol. 2025;161(11):1140-1147.
- Damian DL. Photoprotective effects of nicotinamide. Photochem Photobiol Sci. 2010;9(4):578-585.
- National Institutes of Health, Office of Dietary Supplements. Niacin (Vitamin B3) — Fact Sheet for Health Professionals.
- Wenande E, Hastrup A, Wiegell S, et al. Human papillomavirus vaccination and actinic keratosis burden: the VAXAK randomized clinical trial. JAMA Dermatol. 2025;161(6):605-614.
- Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136(12):1524-1530.
- Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681-1691.
- Schmitt J, Seidler A, Diepgen TL, Bauer A. Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol. 2011;164(2):291-307.
- Newton-Bishop JA, Beswick S, Randerson-Moor J, et al. Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol. 2009;27(32):5439-5444.
- De Smedt J, Van Kelst S, Janssen H, et al. High-dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: a randomized double-blind placebo-controlled study (ViDMe trial). Br J Dermatol. 2024;191(6):886-896.
Related
Related reading
- Sun protection beyond sunscreen — clothing, hats, and shade
- Vitamin B3 (nicotinamide) — the DNA-repair protocol for skin cancer prevention
- Gardasil 9 (HPV vaccine) for actinic keratoses — the off-label evidence
- Treating sun damage to prevent future skin cancers (field therapy)
- Advanced protection for high-risk groups — transplant, genetics and occupational risk
- Optimising vitamin D and nutrition for sun-avoidant and high-risk patients
- Vitamin D and skin cancer — what the evidence actually shows
- Life after skin cancer — surveillance and self-monitoring
Related treatments

By Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA
Last reviewed 2026-06-06 · Editorial policy